Two years ago, President Biden signed into law a transformative piece of legislation – the Inflation Reduction Act, marking a historic effort to lower healthcare costs for millions of Americans.
Also known as the lower-cost prescription drug law, this Act has brought about significant changes in the healthcare landscape, particularly for people with Medicare. This law not only created the first-ever annual cap on out-of-pocket drug costs for Medicare beneficiaries, but also capped the cost of insulin at $35 per month, empowered Medicare to directly negotiate drug prices, and made Affordable Care Act (ACA) marketplace plans more affordable, leading to the lowest uninsured rate in U.S. history.
As we celebrate the second anniversary of this landmark legislation, it is clear that the Inflation Reduction Act is making a substantial impact on the lives of millions. “Two years in, the Inflation Reduction Act is lowering healthcare costs for millions of Americans,” U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said. “As a result of this law, we’ve achieved something decades in the making: putting Medicare on a level playing field by negotiating for lower drug prices. The Biden-Harris Administration is delivering lower prescription drug costs, making health insurance more affordable, and making the economy work for working families.”
Officials recently announced new lower prices for the first 10 drugs negotiated under the new Medicare Drug Price Negotiation Program. If these new prices had been in effect last year, Medicare would have saved an estimated $6 billion – approximately 22 percent, across the selected drugs. The negotiated prices, which offer discounts ranging from 38 to 79 percent off the list prices, are expected to save people with Medicare prescription drug coverage about $1.5 billion in out-of-pocket costs in 2026.
These changes are part of a broader effort to ensure that Medicare remains strong for future generations. Beyond the first 10 drugs, the Inflation Reduction Act has already implemented several other provisions to reduce drug prices, including capping insulin costs at $35 per month for Medicare beneficiaries and providing recommended vaccines for free to people with Medicare Part D. In 2023 alone, more than 10 million people received a free vaccine.
Starting in 2024, some Medicare enrollees will see their out-of-pocket drug costs capped at around $3,500. By April 1, 2024, over 260,000 people had benefited from this cap, meaning they will pay no more out of pocket for the remainder of the year. Additionally, the Inflation Reduction Act has expanded eligibility for the Low-Income Subsidy program, known as Extra Help, which provides $0 premiums, $0 deductibles, and fixed, reduced copays to more enrollees.
Another critical provision of the law requires drug companies to pay a rebate to Medicare if they raise their prices faster than the rate of inflation. As the Biden-Harris Administration continues to implement these provisions, Americans will continue to see significant savings on their healthcare costs. In 2025, all Medicare prescription drug enrollees will have their out-of-pocket costs capped at $2,000 – a monumental change that will provide financial relief to millions.
However, the enhanced ACA subsidies are set to expire at the end of 2025 unless Congress takes action. To ensure that millions do not lose access to affordable health coverage, it is crucial that these enhanced subsidies be made permanent.
The Inflation Reduction Act represents a significant step forward in making healthcare more affordable and accessible, but continued efforts are needed to maintain these gains.
As the Centers for Medicare & Medicaid Services (CMS) clarifies existing Medicare policies like the Two-Midnight Rule, which guides the appropriateness of inpatient services, some
Today we’re talking about a major shift in Medicare rules that’s going to impact hospitals, surgeons, and physician advisors alike: the phasing out of the
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
